Skip to main content

Table 1 Characteristics at baseline and after trauma but prior to start of resuscitation

From: Therapeutic application of recombinant human ADAMTS-13 improves shock reversal and coagulation status in a trauma hemorrhage and transfusion rat model

 

Control

ADAMTS-13

 

Baseline

Hemorrhagic shock

Baseline

Hemorrhagic shock

Clinical parameters

 n

7

8

 Weight (g)

373.6 (13.4)

360.6 (24.8)

 Temperature (°C)

36.6 (0.8)

36.9 (0.5)

36.8 (0.6)

36.8 (0.9)

Chemical lab

 Hemoglobin level (g/dL)

14.0 (1.2)

11.1 (1.0)†

15.7 (0.5)*

11.7 (0.6)†

 Creatinine (μmol/L)

25.4 (3.5)

ND

23.4 (2.9)

ND

 ASAT (U/L)

63.9 (4.0)

ND

63.3 (9.5)

ND

 ALAT (U/L)

54.6 (4.1)

ND

53.1 (6.9)

ND

 LDH (U/L)

153.7 (89.0)

ND

129.6 (49.1)

ND

 vWF antigen (% of poolplasma)

72 (29–84)

ND

94 (86–101)*

ND

Blood gas

 pH

7.44 (0.07)

7.32 (0.11)

7.38 (0.04)

7.33 (0.07)

 pCO2 (mmHg)

35.4 (5.3)

28.2 (8.7)†

41.0 (7.4)

34.6 (6.6)

 HCO3− (mEq/L)

23.3 (1.9)

15.1 (6.5)†

23.6 (2.5)

17.5 (1.8)†

 BD (mmol/L)

− 0.5 (2.6)

− 9.9 (7.5)†

− 1.4 (1.6)

− 7.6 (2.1)†

 Lactate (mmol/L)

0.9 (0.3)

5.2 (4.7)

0.9 (0.3)

3.7 (1.2)†

Hemodynamics

 MAP (mmHg)

133 (15)

43 (11)†

149 (9)

44 (3)†

 Heartrate (bpm)

282 (32)

265 (54)

270 (18)

252 (31)

ROTEM

 Clotting time (s)

49.6 (5.5)

49.3 (3.1)

49.6 (4.6)

43.1 (5.0)†

 Mean clot firmness (mm)

69.7 (2.9)

64.0 (4.7)†

69.9 (1.5)

68.9 (2.1)

 α-angle (°)

81.7 (1.1)

80.1 (1.8)†

82.5 (0.5)

81.9 (0.6)†

 Maximum lysis (%)

5.9 (3.1)

0.9 (0.7)†

2.3 (2.3)*

0.9 (1.5)†

  1. Values are presented as mean and standard deviation (SD) or median and interquartile range (IQR)
  2. BD base deficit, MAP mean arterial pressure, ND not done, NA not applicable
  3. *Significantly different from control, p < 0.05
  4. †Significantly different from baseline, p < 0.05